We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 303 results
  1. Short-chain fatty acids–microbiota crosstalk in the coronavirus disease (COVID-19)

    The novel coronavirus disease (COVID-19) still remains a major challenge to the health-care systems worldwide, inciting ongoing search for...

    Jakub Włodarczyk, Bartłomiej Czerwiński, Jakub Fichna in Pharmacological Reports
    Article Open access 27 September 2022
  2. The Effect of Phytocompounds of Medicinal Plants on Coronavirus (2019-NCOV) Infection

    The recent outbreak of coronavirus disease 2019 (COVID-19) is a respiratory infection and it can spread from animal to person, person to person...

    Article 31 January 2022
  3. Knowledge and perceptions of pharmacists’ readiness during coronavirus pandemic: the case of United Arab Emirates

    Background

    With the outbreak of Coronavirus infection (COVID-19), pharmacists play an important role in supporting local health during this emergency.

    ...
    Iman A. Basheti, Nizar M. Mhaidat, ... Eman Abu-Gharbieh in Journal of Pharmaceutical Policy and Practice
    Article Open access 02 December 2021
  4. Coronaviruses and Nature’s Pharmacy for the Relief of Coronavirus Disease 2019

    Current challenges to the treatment of coronavirus disease 2019 should open new prospects in the search for novel drugs from medicinal plants and...

    Kazhila C. Chinsembu in Revista Brasileira de Farmacognosia
    Article 06 October 2020
  5. Coronavirus Disease 2019 and Herbal Therapy: Pertinent Issues Relating to Toxicity and Standardization of Phytopharmaceuticals

    Coronavirus disease 2019 (COVID-19) is a virulent viral disease that has now become a public health emergency of global significance and still...

    Kayode Komolafe, Titilope Ruth Komolafe, ... Afolabi Akintunde Akindahunsi in Revista Brasileira de Farmacognosia
    Article 11 March 2021
  6. Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a theoretical perspective

    Background

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes pulmonary injury or multiple-organ injury by various pathological...

    Seyed Hootan Hamidi, Sandhya Kadamboor Veethil, Seyedeh Harir Hamidi in Pharmacological Reports
    Article 21 April 2021
  7. Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion

    The Coronavirus Disease 2019 (COVID-19) is rapidly spreading throughout the world after emerging in China in December 2019. Currently, there are no...

    Peter Yamoah, Thelma Mpoku Alalbila, ... Frasia Oosthuizen in Therapeutic Innovation & Regulatory Science
    Article 01 May 2020
  8. In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis

    Background and aims

    The idea of treating COVID-19 with statins is biologically plausible, although it is still controversial. The systematic review...

    Hikmat Permana, Ian Huang, ... Nanny Natalia M. Soetedjo in Pharmacological Reports
    Article 20 February 2021
  9. Coronavirus outbreaks: prevention and management recommendations

    Zakir Khan, Khayal Muhammad, ... Hazir Rahman in Drugs & Therapy Perspectives
    Article 07 March 2020
  10. Nirmatrelvir plus ritonavir in COVID-19: a profile of its use

    Oral nirmatrelvir plus ritonavir (Paxlovid ) is an effective treatment option for coronavirus disease 2019 (COVID-19), the illness caused by severe...

    Hannah A. Blair in Drugs & Therapy Perspectives
    Article 06 December 2022
  11. Is Pakistan prepared to tackle the coronavirus epidemic?

    Muhammad Saqlain, Muhammad Muddasir Munir, ... Sohail Kamran in Drugs & Therapy Perspectives
    Article 20 March 2020
  12. Knowledge and beliefs towards universal safety precautions during the coronavirus disease (COVID-19) pandemic among the Indian public: a web-based cross-sectional survey

    Background

    The novel coronavirus disease 2019 (COVID-19) is considered the most serious global health threat in recent times. As there is a current...

    Sai Krishna Gudi, Manik Chhabra, ... Sanath Nyamagoud in Drugs & Therapy Perspectives
    Article 04 July 2020
  13. Strategy for the Choice of Disinfectants in Practical Medicine and Production

    The problem of the strategy for choosing disinfectants in practical medicine is considered. The pandemic of the new coronavirus infection posed new...

    O. Yu. Bogdanova, T. F. Chemykh in Pharmaceutical Chemistry Journal
    Article 09 May 2023
  14. In Vitro Study of the Cytotoxic and Immunotropic Effects of Molnupiravir and Favipiravir

    The effects of the antiviral drugs molnupiravir and favipiravir on the viability of human embryonic lung cells and the production of cytokines by...

    E. P. Brodovskaya, K. Ya. Zaslavskaya, ... N. A. Pyataev in Pharmaceutical Chemistry Journal
    Article 01 February 2024
  15. Neurological consequences of COVID-19

    In December 2019, cases of pneumonia caused by infection with the previously unknown severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),...

    Waldemar Brola, Maciej Wilski in Pharmacological Reports
    Article 30 September 2022
  16. Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently regarded as the twenty-first century’s plague accounting for...

    Marwa O. El-Derany, Diana M. F. Hanna, ... Samar S. Azab in Pharmacological Reports
    Article Open access 16 August 2023
  17. Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy

    The COVID-19 pandemic that started in 2019 and resulted in significant morbidity and mortality continues to be a significant global health challenge,...

    Mahdi Vajdi, Arash Karimi, ... Amirhossein Sahebkar in Pharmacological Reports
    Article 18 March 2024
  18. Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine

    Introduction

    The coronavirus disease (COVID-19) pandemic has placed enormous pressures on the Canadian healthcare system. Patients are expected to...

    Ali Elbeddini, Aniko Yeats in Journal of Pharmaceutical Policy and Practice
    Article Open access 27 May 2020
  19. Recent review of COVID-19 management: diagnosis, treatment and vaccination

    The idiopathic Coronavirus disease 2019 (COVID-19) pandemic outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has...

    Vivek P. Chavda, Suneetha Vuppu, ... Zhe-Sheng Chen in Pharmacological Reports
    Article 10 October 2022
  20. Therapy for HIV-associated cryptococcal meningitis: a case report demonstrating a new treatment approach emphasizing updated treatment guidelines

    Cryptococcal meningitis (CM) remains a significant global health burden, especially for persons living with HIV. Despite effective antiretroviral and...

    David M. Hachey, Brian R. Wood, ... Anushka Burde in Drugs & Therapy Perspectives
    Article 12 June 2023
Did you find what you were looking for? Share feedback.